Americans speak out on cancer

December 17, 2003

Most Americans are far more afraid of cancer than getting into a serious car accident, or being victim of a violent crime or a terrorist attack. A large majority - more than 75 percent - also favors increasing government funding for cancer research, with 63 percent saying they would be willing to double the current federal cancer budget.

These are among the striking results of a nationwide survey that measured public attitudes and opinions about the country's efforts to eliminate cancer. The survey was commissioned by the American Association for Cancer Research (AACR) and the Lance Armstrong Foundation (LAF). Cancer survivor Lance Armstrong, quintuple winner of the Tour de France, and Hamilton Jordan, a three-time cancer survivor and former White House chief of staff, announced the findings today at the National Press Club here as part of a new campaign to make the prevention, cure and survivorship of cancer a priority in next year's presidential elections. About 79 percent of the survey respondents said that it is important that the presidential candidates talk about cancer research and finding a cure for the disease.

"AACR is privileged to work with the Lance Armstrong Foundation and two of the nation's most prominent public figures among cancer survivors," said Margaret Foti, Ph.D., M.D. (h.c.), chief executive officer of the Philadelphia-based association. "Our goal is the same: to conquer cancer.

"Today, advances in technology are making it possible for scientists and physicians to explore new ways to prevent cancer, detect its onset at an earlier stage, and tailor treatments to individuals," added Foti. "We stand at a crossroads in history that could see major progress in lowering suffering and death from this disease."

The opinion research firm of Fairbank, Maslin, Maullin & Associates, in association with pollster Mark Allen of Public Strategies, conducted the bi-partisan survey, interviewing a geographically representative sample of 1,000 Americans, 18 years of age and older. Among other notable responses:

Cancer remains second only to heart disease as the leading cause of death, claiming about 1,500 American lives daily. Economically, the United States lost about $172 billion in the year 2002 from treatment costs, lost productivity and premature deaths from cancer.

"I am living proof of the value of successful cancer research - without it I would not be here today," said testicular cancer survivor and champion cyclist Lance Armstrong. "Other cancer survivors deserve the same opportunity to overcome the disease and live with a great quality of life.

"It's clear that America can do more to help make progress against cancer," Armstrong said. "Our country, including the government and the entire cancer community, needs to make a greater commitment to eliminating this dreadful disease."
Founded in 1907, the American Association for Cancer Research is a professional society of more than 22,000 laboratory, translational, and clinical scientists engaged in cancer research in the United States and in more than 60 other countries. Its principal activities include the publication of five major, peer-reviewed scientific journals: Cancer Research; Clinical Cancer Research; Molecular Cancer Therapeutics; Molecular Cancer Research; and Cancer Epidemiology, Biomarkers & Prevention. AACR's annual meetings - next year in Orlando, Fla., March 27-31 - attract more than 15,000 participants who share new and significant discoveries in the cancer field. Specialty meetings and workshops throughout the year focus on the latest developments in all areas of cancer research.

The Lance Armstrong Foundation (LAF) exists to enhance the quality of life for those living with, through, and beyond cancer. Founded in 1997 by cancer survivor and champion cyclist Lance Armstrong, the LAF seeks to promote the optimal physical, psychological, social recovery and care of cancer survivors and their loved ones. The LAF works to define, refine and improve services for cancer survivors and to facilitate the delivery of those services - with a large dose of hope - to patients, their families, and other loved ones touched by the disease.

American Association for Cancer Research

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to